Kaplan Myron

Avg. Two Year Performance

(4%) Avg. Purchase Return
(2%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%8%4%(4%)(4%)
Purchase Success Rate3 of 122 of 123 of 121 of 120 of 12
Average Sale Return----------
Sale Success Rate----------

Cormedix Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 196.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--